Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | PPM1B | O75688 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.36 |
| ▸ | TFPI2 | P48307 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | PPP5C | P53041 | 1/20 | 0.36 |
| ▸ | PPP1CA | P62136 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7310733 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2KDM4EGMNNPPM1BLMNA | |
| SCHEMBL1330580 | 1.00 | SMN1; SMN2 (0.36) | SMN1; SMN2KDM4EGMNNPPM1BLMNA | |
| SCHEMBL16003245 | 0.82 | KDM4E (0.30) | SMN1; SMN2KDM4EGMNNPPM1BLMNA | |
| SCHEMBL18789034 | 0.78 | POLB (0.36) | — | |
| SCHEMBL16657577 | 0.76 | — | — | |
| SCHEMBL18588303 | 0.76 | — | — | |
| SCHEMBL2692834 | 0.76 | — | — | |
| SCHEMBL7085873 | 0.71 | CA1 (0.32) | SMN1; SMN2CA1CA2CA4KMT2A | |
| SCHEMBL18427530 | 0.71 | SMN1; SMN2 (0.44) | SMN1; SMN2KDM4EGMNNPPM1BLMNA | |
| SCHEMBL7282746 | 0.71 | SMN1; SMN2 (0.33) | SMN1; SMN2KDM4EGMNNPPM1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024175529-A1 | HOT-MELT COMPOSITION | BOSTIK SA (FR) | 2024-08-29 | — | — | WO | claimed |
| EP-4594382-A1 | OPTIONALLY SILYLATED IONIC POLYURETHANE(S) | Bostik SA (FR) | 2025-08-06 | — | — | EP | disclosed |
| CN-120041103-A | Active energy ray-curable adhesive and laminate | 爱天思株式会社 | 2025-05-27 | — | — | CN | disclosed |
| EP-4527993-A1 | METHOD OF MANUFACTURING BIODEGRADABLE NONWOVEN FABRIC AND BIODEGRADABLE NONWOVEN FABRIC MANUFACTURED THEREBY | SK leaveo Co., Ltd. (KR) | 2025-03-26 | — | — | EP | disclosed |
| US-20250075384-A1 | METHOD OF MANUFACTURING BIODEGRADABLE NONWOVEN FABRIC AND BIODEGRADABLE NONWOVEN FABRIC MANUFACTURED THEREBY | SK LEAVEO CO., LTD. (KR) | 2025-03-06 | — | — | US | disclosed |
| WO-2025009755-A1 | BIODEGRADABLE BUOY AND MANUFACTURING METHOD THEREOF | 에스케이리비오 주식회사 | 2025-01-09 | — | — | WO | disclosed |
| WO-2024262832-A1 | BIODEGRADABLE FILM, MANUFACTURING METHOD THEREFOR, AND BIODEGRADABLE RESIN COMPOSITION | 에스케이리비오 주식회사 | 2024-12-26 | — | — | WO | disclosed |
| US-12098242-B2 | Biodegradable polyester resin composition, biodegradable polyester film including the same and biodegradable molded article including biodegradable polyester resin composition | ECOVANCE CO. LTD. (KR) | 2024-09-24 | — | — | US | disclosed |
| WO-2024175529-A1 | HOT-MELT COMPOSITION | BOSTIK SA (FR) | 2024-08-29 | — | — | WO | disclosed |
| US-11999847-B2 | Biodegradable molded article and biodegradable polyester resin composition | ECOVANCE CO. LTD. (KR) | 2024-06-04 | — | — | US | disclosed |
| WO-2004110609-A2 | CATALYTIC ASYMMETRIC DESYMMETRIZATION OF PROCHIRAL AND MESO CYCLIC ANHYDRIDES | BRANDEIS UNIVERSITY (US) | 2004-12-23 | — | — | WO | disclosed |
| US-20040082809-A1 | Catalytic asymmetric desymmetrization of prochiral and meso compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-04-29 | — | — | US | disclosed |
| US-20030171610-A1 | Catalyst asymmetric desymmetrization of prochiral compounds | DENG LI (US) | 2003-09-11 | — | — | US | disclosed |
| US-6580003-B2 | Reacting a prochiral compound comprising two chiral centers, and internal plane of symmetry or point of symmetry or both, with a nucleophile in presence of a chiral, non-racemic tertiary amine catalyst, thereby producing a chiral compound | BRANDEIS UNIVERSITY | 2003-06-17 | — | — | US | disclosed |
| EP-1268368-A2 | CATALYTIC ASYMMETRIC DESYMMETRIZATION OF MESO COMPOUNDS | Brandeis University (US) | 2003-01-02 | — | — | EP | disclosed |
| US-20020038048-A1 | Catalytic asymmetric desymmetrization of meso compounds | BRANDEIS UNIVERSITY | 2002-03-28 | — | — | US | disclosed |
| WO-2001074741-A2 | CATALYTIC ASYMMETRIC DESYMMETRIZATION OF MESO COMPOUNDS | BRANDEIS UNIVERSITY (US) | 2001-10-11 | — | — | WO | disclosed |
| EP-0505481-A1 | 2-SUBSTITUTED 4,5-DIPHENYL-IMIDAZOLES | RHONE-POULENC SANTE (FR) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991009030-A1 | 2-SUBSTITUTED 4,5-DIPHENYL-IMIDAZOLES | RHONE-POULENC SANTE (FR) | 1991-06-27 | — | — | WO | disclosed |
| US-4996158-A | Optical resolution of racemic alcohols | LION CORPORATION, 3-7, HONJO 1-CHOME, SUMIDA-KU, TOKYO, JAPAN | 1991-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020038048-A1 | Catalytic asymmetric desymmetrization of meso compounds | DNPH1, HDHD5, GNE | SMN1; SMN2 3998/4885KDM4E 2135/4885GMNN 402/4885 |
| US-20030171610-A1 | Catalyst asymmetric desymmetrization of prochiral compounds | HPSE, HPD, APEH | SMN1; SMN2 4274/4885KDM4E 2505/4885GMNN 546/4885 |
| US-20040082809-A1 | Catalytic asymmetric desymmetrization of prochiral and meso compounds | CA14, CA12, HPSE | SMN1; SMN2 4193/4885KDM4E 2311/4885GMNN 686/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.